Why the Virtus Health Ltd share price lost 7% on today's results

The Virtus Health Ltd (ASX:VRT) share price fell 7% after the company released its annual results this morning.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Virtus Health Ltd (ASX: VRT) share price fell 7% to $5.26 after the company released its annual results to the market this morning. Here's what you need to know:

  • Revenue fell 1.8% to $257 million
  • Group earnings before interest, tax, depreciation and amortisation (EBITDA) fell 6% to $65 million
  • Net profit after tax (NPAT) fell 15% to $28 million
  • Earnings per share of 35 cents
  • Dividends of 25 cents per share
  • Net debt of $126 million

So what?

Much like Monash IVF Group Ltd (ASX: MVF) which reported yesterday, Virtus Health also reported a decline in overall market activity. Virtus reported that its total cycles fell 3.7% on a 'like-for-like' basis, however group cycles overall were flat due to new clinics and growth in Ireland.

Virtus continues to expand into ancillary services such as diagnostics and genetic testing, and the company may be able to grow further by expanding these services to all its clinics. However, there's no getting away from the fact that business is sort-of cyclical (no pun intended) due to the fluctuations in demand for IVF. When the market is down, sales go backwards but costs (staff, rent, etc) remain relatively fixed, which can punish profits – as happened this year.

Now what?

The company continues to expand in new markets such as Ireland, Singapore, and Denmark, and the Irish segment grew strongly this year. As Virtus grows further overseas, results should hopefully become 'smoother' because the Australian segment will become a smaller part of Group operations.

Virtus carries a meaningful amount of debt, and my view is that growth would come to a stop if there was, for example, some sort of regulation that hurt its profits. Again that risk becomes less relevant with international expansion, and with a long-term trend towards increasing demand for fertility services, Virtus could prove a solid buy over the long term.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »